Client NewsRoquefort Therapeutics plc: Commencement of Trading on US OTCQB Venture Market
Roquefort Therapeutics (LSE:ROQ), the Main Market listed biotech company focused on early-stage opportunities in the biotechnology sector, is pleased to announce that trading in the Company’s Ordinary Shares of one pence each (“Ordinary Shares”) has commenced on the OTCQB Venture Market in the United States. The Company’s OTCQB shares have the ticker: ROQAF
There is no associated capital raise with this cross trading and Roquefort Therapeutics’s Ordinary Shares will continue to trade on its primary listing, the Main Market of the London Stock Exchange, under the ticker ROQ.
OPEN AN ACCOUNT
If you are interested in opening an account with Optiva Securities, please fill in the details on the apply button.
Please ensure that the information you entered is accurate, and that your “Caps Lock” key is set correctly.